Role of c-Src in human MCF7 breast cancer cell tumorigenesis.
about
p27 phosphorylation by Src regulates inhibition of cyclin E-Cdk2Non-cysteine linked MUC1 cytoplasmic dimers are required for Src recruitment and ICAM-1 binding induced cell invasionSKI-606 (bosutinib), a novel Src kinase inhibitor, suppresses migration and invasion of human breast cancer cells.Regulation of SRC family kinases in human cancersCYP3A4 mediates growth of estrogen receptor-positive breast cancer cells in part by inducing nuclear translocation of phospho-Stat3 through biosynthesis of (±)-14,15-epoxyeicosatrienoic acid (EET)A RNA interference screen identifies the protein phosphatase 2A subunit PR55gamma as a stress-sensitive inhibitor of c-SRCSH3 domain of c-Src governs its dynamics at focal adhesions and the cell membrane.c-Src-mediated epithelial cell migration and invasion regulated by PDZ binding site.Validation of the Cancer BioChip System as a 3D siRNA screening tool for breast cancer targetsThe direct effect of focal adhesion kinase (FAK), dominant-negative FAK, FAK-CD and FAK siRNA on gene expression and human MCF-7 breast cancer cell tumorigenesis.Differential up-regulation of MAP kinase phosphatases MKP3/DUSP6 and DUSP5 by Ets2 and c-Jun converge in the control of the growth arrest versus proliferation response of MCF-7 breast cancer cells to phorbol ester.Subcellular localization of total and activated Src kinase in African American and Caucasian breast cancerMolecular mechanisms of action and potential biomarkers of growth inhibition of dasatinib (BMS-354825) on hepatocellular carcinoma cells.SRC drives growth of antiestrogen resistant breast cancer cell lines and is a marker for reduced benefit of tamoxifen treatmentSelective inhibition of RET mediated cell proliferation in vitro by the kinase inhibitor SPP86.miRNA-34b as a tumor suppressor in estrogen-dependent growth of breast cancer cells.Interrelationship between protein phosphatase 1 and TGF-{beta} in regulating motility and cytoskeletal architecture of endothelial cells.Cyr61 as mediator of Src signaling in triple negative breast cancer cells.The oncoprotein HBXIP modulates the feedback loop of MDM2/p53 to enhance the growth of breast cancer.Dasatinib inhibits c-src phosphorylation and prevents the proliferation of Triple-Negative Breast Cancer (TNBC) cells which overexpress Syndecan-Binding Protein (SDCBP).Src promotes cutaneous wound healing by regulating MMP-2 through the ERK pathway.Phosphorylated c-Src is a novel predictor for recurrence in cervical squamous cell cancer patientsApoptosis of estrogen-receptor negative breast cancer and colon cancer cell lines by PTP alpha and src RNAi.mda-9/Syntenin promotes metastasis in human melanoma cells by activating c-Src.Targeting Src in breast cancer.The cell surface GRP78 facilitates the invasion of hepatocellular carcinoma cells.Infectious Bursal Disease Virus Activates c-Src To Promote α4β1 Integrin-Dependent Viral Entry by Modulating the Downstream Akt-RhoA GTPase-Actin Rearrangement Cascade.Glucocorticoids induce production of reactive oxygen species/reactive nitrogen species and DNA damage through an iNOS mediated pathway in breast cancer.Tetracycline regulated systems in functional oncogenomics.Kindlin-2 phosphorylation by Src at Y193 enhances Src activity and is involved in Migfilin recruitment to the focal adhesions.KX-01, a novel Src kinase inhibitor directed toward the peptide substrate site, synergizes with tamoxifen in estrogen receptor α positive breast cancer.Dasatinib synergizes with doxorubicin to block growth, migration, and invasion of breast cancer cells.Gab2 and Src co-operate in human mammary epithelial cells to promote growth factor independence and disruption of acinar morphogenesis.4-Aryl-4H-naphthopyrans derivatives: one-pot synthesis, evaluation of Src kinase inhibitory and anti-proliferative activities.Regulation of cross-linked actin network (CLAN) formation in human trabecular meshwork (HTM) cells by convergence of distinct beta1 and beta3 integrin pathways.AC-93253 iodide, a novel Src inhibitor, suppresses NSCLC progression by modulating multiple Src-related signaling pathways.miR205 inhibits stem cell renewal in SUM159PT breast cancer cells.SRC increases MYC mRNA expression in ER+ breast cancer via mRNA stabilization and inhibition of p53 function.YAP/TAZ Activation as a Target for Treating Metastatic Cancer.
P2860
Q24294568-59949B19-621A-4595-BC90-997EF668528CQ24317461-DD414D6C-59F1-461C-B330-9AC837050C46Q24656966-AE6194EA-965B-4FDE-9A24-547600479DDEQ28243770-1ED65F75-30FC-4B5E-8DDC-BBDF5D7A2436Q28307304-C93DC977-3752-49D6-A474-E8C49677631EQ28471792-A34BDBC9-C416-429D-B98F-37A635ED4209Q30009127-DA720444-6724-4F35-A509-2BBDB08F0602Q30481162-B14DED72-6B78-47A8-AB43-5B68B2AD806DQ31103913-2FA5305B-1394-45CB-9000-C60514C78A81Q33492610-E605D441-31B7-47C9-A1EB-F8EEB9979C0DQ34074438-64958154-4BF8-422F-856E-6FC5790BE2C1Q34211720-AD188F02-6064-4E64-A9EE-3E0107C78015Q34747847-C0DFC40B-7B44-4EE5-973E-986296B505F4Q35113027-729E1AF5-339C-4B9A-84B0-752682BFEEF3Q35437491-66E3C01C-6B92-43C5-A29B-5F4605AC8D91Q35889599-6501D6F3-D023-413D-BDD3-E0B98D951CDFQ35915611-05C12143-034C-418C-AAEB-198A68D0E301Q35955373-B74DE5A0-AC1B-488B-8C52-C899827ED4C7Q36049982-18E53C1B-CDFC-43A3-8550-A05E9746CAAAQ36265028-ED6AA66F-2E18-4923-83B5-864A3355ACC6Q36630656-CD01F572-2BB2-43B4-8E31-7E847FA34730Q36853436-A5DE873D-BAD8-44E2-A2E8-999F93308BB0Q36932170-4D0AAA73-2D37-4D18-B5A5-227BF027778CQ36949152-734649A8-A4B5-4E6E-9096-E66DE68DB53AQ37167029-E72F9C25-39AD-4FB0-9C4E-FF5BBC70FEC5Q37409184-EA094AF4-FBFE-44DB-86D1-33C334BC44C3Q37593168-1EAED046-F2E6-4D56-B84A-E387D1C84538Q37720884-6BD3AC7D-9479-4AC1-820D-4B535E185605Q38104340-8E06D58E-2058-42C0-A972-2A4880BC89F3Q38868155-64A4FAEC-419B-4248-96EB-EF0F16917A95Q39555328-39EFAEF9-D51B-4A47-9463-3BF8E7C51DE6Q39840354-8D5A2D22-EC68-4835-8875-0620BE93E30AQ40052820-74CB00A7-3288-466B-ABC4-3CFAE202F30EQ41050465-EFE71EBD-3504-4337-B442-C6B7FE52087EQ41206022-A3E3E501-F5EE-4653-8930-EFCBBD5BA807Q46752829-7C815839-30C6-413B-829A-12EC110FEBCFQ47124421-ED522BD0-7E00-4096-9D56-270E6850E827Q47230860-90772B13-96EE-4124-BCDD-E7A2E0A8BBC2Q54977387-30938387-9D9E-44D3-ADA0-E7B08CB3DB07
P2860
Role of c-Src in human MCF7 breast cancer cell tumorigenesis.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Role of c-Src in human MCF7 breast cancer cell tumorigenesis.
@en
type
label
Role of c-Src in human MCF7 breast cancer cell tumorigenesis.
@en
prefLabel
Role of c-Src in human MCF7 breast cancer cell tumorigenesis.
@en
P2093
P2860
P356
P1476
Role of c-Src in human MCF7 breast cancer cell tumorigenesis.
@en
P2093
Ana Aranda
Annarica Calcabrini
Carlos Gamallo
Jorge Martín-Pérez
José Manuel García-Martínez
José Palacios
Lorena González
María Teresa Agulló-Ortuño
P2860
P304
20851-20864
P356
10.1074/JBC.M601570200
P407
P577
2006-05-25T00:00:00Z